Dabrafenib 50 mg ,75 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 50 mg ,75 mg
Reference Brands: Tafinlar (USA/EU)
Category: Oncology Cancer Care
Dabrafenib is a Oncology Cancer Care product available as Capsules in strengths 50 mg ,75 mg. It corresponds to the reference brand Tafinlar (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Dabrafenib is a targeted anticancer medication used for the treatment of cancers that carry specific BRAF gene mutations, particularly the BRAF V600E mutation. It works as a BRAF kinase inhibitor, blocking the abnormal B-Raf protein that drives uncontrolled cell growth and tumor development in mutation-positive cancers. By inhibiting this signaling pathway, dabrafenib helps slow or stop the growth of cancer cells.
It is used as a single agent for the treatment of unresectable or metastatic melanoma with BRAF V600E mutation and is also widely used in combination with the MEK inhibitor trametinib for broader mutation-positive cancers. Combination therapy is approved for indications including metastatic melanoma, metastatic non-small cell lung cancer, anaplastic thyroid cancer, and certain other unresectable or metastatic solid tumors with BRAF V600E mutation. Treatment selection is based on confirmed molecular testing. Dabrafenib is marketed under the brand name Tafinlar and is prescribed under oncology specialist supervision, with regular monitoring to manage safety and treatment response. It represents an important precision therapy option in mutation-driven cancer care.
Dabrafenib — third party manufacturing & bulk supply
Dabrafenib 50 mg ,75 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Dabrafenib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Dabrafenib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Dabrafenib is used for the treatment of BRAF V600 mutation-positive melanoma, non-small cell lung cancer, and certain other mutation-driven tumors, either alone or in combination with other targeted therapies.
It is a synthetic small-molecule BRAF kinase inhibitor formulated as dabrafenib mesylate for oral administration.
The trade name is Tafinlar.
It is developed and marketed by Novartis.
The generic name is dabrafenib mesylate.
The brand name is Tafinlar.
It is manufactured in GMP-approved pharmaceutical facilities by Novartis and its authorized manufacturing partners across multiple regions.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
